These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

76 related items for PubMed ID: 309464

  • 41. Mixed connective tissue disease in childhood. A clinical and serologic survey.
    Singsen BH, Bernstein BH, Kornreich HK, King KK, Hanson V, Tan EM.
    J Pediatr; 1977 Jun; 90(6):893-900. PubMed ID: 300795
    [Abstract] [Full Text] [Related]

  • 42. Antinuclear antibodies are not increased in the early phase of Borrelia infection.
    Spiewak R, Stojek NM, Chmielewska-Badora J.
    Ann Agric Environ Med; 2004 Jun; 11(1):145-8. PubMed ID: 15236512
    [Abstract] [Full Text] [Related]

  • 43. [The value of RNase-ANA determinations for the diagnosis of Sharp syndrome (mixed connective tissue disease) (author's transl)].
    Rosenthal M.
    Klin Wochenschr; 1977 Jan 01; 55(1):31-5. PubMed ID: 299898
    [Abstract] [Full Text] [Related]

  • 44. [Renal histology in 44 patients with specific antibodies of soluble nuclear antigens].
    Meyer O, Gaudreau A, Peltier AP.
    Rev Rhum Mal Osteoartic; 1980 Oct 01; 47(10):561-8. PubMed ID: 6970963
    [Abstract] [Full Text] [Related]

  • 45. The clinical significance of the in vivo antinuclear antibody phenomenon.
    Williams WV, Barjenbrach P, Adelstein E, Sharp GC, Walker SE.
    Arch Pathol Lab Med; 1986 Sep 01; 110(9):798-802. PubMed ID: 3530186
    [Abstract] [Full Text] [Related]

  • 46. Assays for Sm and RNP antibodies: pitfalls and technical considerations.
    Molden DP, Suzuki H, Nakamura RM.
    Diagn Immunol; 1985 Sep 01; 3(1):24-8. PubMed ID: 3922661
    [Abstract] [Full Text] [Related]

  • 47. Patterns of clinical disease associated with antibodies to nuclear ribonucleoprotein.
    Maddison PJ, Mogavero H, Reichlin M.
    J Rheumatol; 1978 Sep 01; 5(4):407-11. PubMed ID: 310884
    [Abstract] [Full Text] [Related]

  • 48. [Spectrum of antinuclear and anti-cytoplasmic antibodies in dermatomyositis and polymyositis overlap syndromes].
    Meurer M, Hausmann-Martinez-Pardo G, Braun-Falco O.
    Hautarzt; 1989 Oct 01; 40(10):623-9. PubMed ID: 2482267
    [Abstract] [Full Text] [Related]

  • 49. Juvenile linear scleroderma associated with serologic abnormalities.
    Woo TY, Rasmussen JE.
    Arch Dermatol; 1985 Nov 01; 121(11):1403-5. PubMed ID: 3876808
    [Abstract] [Full Text] [Related]

  • 50. [The Sharp syndrome (mixed connective tissue diseases) (author's transl)].
    Seelig HP.
    Immun Infekt; 1981 Nov 01; 9(6):223-31. PubMed ID: 6978280
    [Abstract] [Full Text] [Related]

  • 51. Speckled (particulate) epidermal nuclear IgG deposition in normal skin. Correlation of clinical features and laboratory findings in 46 patients with a subset of connective tissue disease characterized by antibody to extractable nuclear antigen.
    Prystowsky SD, Tuffanelli DL.
    Arch Dermatol; 1978 May 01; 114(5):705-10. PubMed ID: 348115
    [Abstract] [Full Text] [Related]

  • 52. [Mixed connective tissue disease (Sharp's syndrome)].
    Suţeanu S, Moangă M.
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1978 May 01; 30(5):385-92. PubMed ID: 32591
    [No Abstract] [Full Text] [Related]

  • 53. Patients with arthritis and anti-U1-RNP antibodies: a 10-year follow-up.
    Piirainen HI.
    Br J Rheumatol; 1990 Oct 01; 29(5):345-8. PubMed ID: 2224402
    [Abstract] [Full Text] [Related]

  • 54. Mixed connective tissue disease in children.
    Peskett SA, Ansell BM, Fizzman P, Howard A.
    Rheumatol Rehabil; 1978 Nov 01; 17(4):245-8. PubMed ID: 310575
    [Abstract] [Full Text] [Related]

  • 55. Autoantibody profile in juvenile chronic arthritis.
    Leak AM.
    Ann Rheum Dis; 1988 Mar 01; 47(3):178-82. PubMed ID: 3281608
    [Abstract] [Full Text] [Related]

  • 56. The speckled epidermal nuclear immunofluorescence of mixed connective tissue disease seems to develop as an in vitro phenomenon.
    Iwatsuki K, Tagami H, Imaizumi S, Ginoza M, Yamada M.
    Br J Dermatol; 1982 Dec 01; 107(6):653-7. PubMed ID: 6756463
    [Abstract] [Full Text] [Related]

  • 57. Clinical significance of antibodies to soluble extractable nuclear antigens (anti-ENA).
    Gaudreau A, Amor B, Kahn MF, Ryckewaert A, Sany J, Peltier AP.
    Ann Rheum Dis; 1978 Aug 01; 37(4):321-7. PubMed ID: 308354
    [Abstract] [Full Text] [Related]

  • 58. [Effective treatment with low-dose methotrexate pulses of a child of mixed connective tissue disease with severe myositis refractory to corticosteroid].
    Nakata S, Uematsu K, Mori T, Mitsushita N, Kinoshita T, Ishioka C, Mutou K, Yokota S, Hirose Y, Komiyama A.
    Nihon Rinsho Meneki Gakkai Kaishi; 1997 Jun 01; 20(3):178-83. PubMed ID: 9256610
    [Abstract] [Full Text] [Related]

  • 59. A histologic evaluation of mixed connective tissue disease in childhood.
    Singsen BH, Swanson VL, Bernstein BH, Heuser ET, Hanson V, Landing BH.
    Am J Med; 1980 May 01; 68(5):710-7. PubMed ID: 6966469
    [No Abstract] [Full Text] [Related]

  • 60. Anti-ENA antibody in serum determined by ELISA-technique. Description of method and recommended procedure.
    Struckmann J, Manthorpe R, Bendixen G.
    Allergy; 1981 Aug 01; 36(6):397-403. PubMed ID: 6976131
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 4.